ARDINGLY COURT SURGERY — All Prescriptions & Medications — Page 10
Practice Code: G81006 | BRIGHTON, BN2 1SS
Showing results 451-485 of 485
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 13 | 13 | £66 | -68.1% ▼ | |
| 13 | 65 | £170 | +39.0% ▲ | |
| Dipyridamole | 12 | 1,620 | £337 | -53.3% ▼ |
| Nitrazepam | 12 | 522 | £28 | -76.9% ▼ |
| Disulfiram | 12 | 364 | £1.3K | -19.0% ▼ |
| Liraglutide | 12 | 36 | £1.4K | +124.2% ▲ |
| Capsaicin | 12 | 1,080 | £404 | +52.0% ▲ |
| Pimecrolimus | 12 | 670 | £400 | -29.1% ▼ |
| 12 | 130 | £264 | -23.5% ▼ | |
| 12 | 334 | £1.2K | -69.5% ▼ | |
| 12 | 72 | £303 | -72.7% ▼ | |
| 12 | 300 | £408 | +44.6% ▲ | |
| 12 | 540 | £1.7K | +14.4% ▲ | |
| 12 | 750 | £2.9K | -16.1% ▼ | |
| Bupropion hydrochloride | 11 | 928 | £615 | +1.8% vs avg |
| Dutasteride | 11 | 490 | £31 | -78.6% ▼ |
| Levonorgestrel | 11 | 11 | £879 | -70.9% ▼ |
| Tacrolimus | 11 | 1,100 | £1.6K | -58.9% ▼ |
| Terbinafine hydrochloride | 11 | 465 | £81 | -70.4% ▼ |
| 11 | 175 | £20 | -59.1% ▼ | |
| 11 | 190 | £122 | -85.8% ▼ | |
| Fluvastatin sodium | 10 | 560 | £67 | -56.8% ▼ |
| Atomoxetine hydrochloride | 10 | 280 | £688 | -70.4% ▼ |
| Oestrogens conjugated | 10 | 1,008 | £307 | -51.0% ▼ |
| Calcium carbonate | 10 | 1,240 | £105 | -84.8% ▼ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 10 | 70.8K | £634 | -83.6% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 10 | 208.5K | £6.8K | -6.0% ▼ |
| Tube feed additive 1 kcal/ml higher protein liquid (0914051) | 10 | 17.3K | £618 | -26.4% ▼ |
| Febuxostat | 10 | 448 | £35 | -73.2% ▼ |
| Tafluprost | 10 | 381 | £226 | -46.1% ▼ |
| 10 | 350 | £35 | -26.8% ▼ | |
| 10 | 190 | £97 | -65.5% ▼ | |
| 10 | 600 | £244 | -48.3% ▼ | |
| 10 | 380 | £204 | +83.8% ▲ | |
| 10 | 1,450 | £291 | -61.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.